This brief presents information on qualified health plans (QHPs) available in the Exchange for states that use the HealthCare.gov platform, including estimates for issuer participation, health plan options, premiums, and subsidies in the upcoming open enrollment period (OEP), and trends since the first OEP. National estimates and summary tables ar
Did you mean: dataset?
1 - 20 of 440
The prices charged by drug manufacturers to wholesalers and distributors (commonly referred to as exmanufacturers prices) in the United States are 1.8 times higher than in other countries for the top drugs by total expenditures separately paid under Medicare Part B. U.S. prices were higher for most of the drugs included in the analysis, and U.S. p
This is the PDF version of the list of Funding Opportunity Announcements & NIH Resources for the October 2018 meeting of the Advisory Council on Alzheimer's Research, Care, and Services.
This is the PDF version of the 2018 Update of the National Plan to Address Alzheimer's Disease. More information about the National Alzheimer's Project Act is available at https://aspe.hhs.gov/national-alzheimers-project-act .
This report highlights key research questions and identifies opportunities to use existing data sources and implement data-linking strategies that can support the HHS five point strategy to combat the opioid crisis.
The OS PCORTF Annual Report provides project descriptions for each of the OS-PCORTF portfolio’s 21 projects that were active in calendar year 2017.
This Brief provides an examination of the amount of time that low-income families from 32 states received child care subsidies. These families began receiving government-funded child care subsidies during Fiscal Year 2012, prior to the reauthorization of the Child Care and Development Block Grant (CCDBG) Act. In general, families utilized chil
Predictive Analytics in Child Welfare: Considerations in Contracting Vendors for Predictive Analytics
An increasing number of child welfare agencies are considering using predictive analytics in their work. Typically they do so by contracting with a vendor to develop and maintain a predictive analytics model that is used by the agency to predict risk of a specified outcome. There are significant differences between contracts for these services and
This is the PDF version of the meeting summary for the April 2018 meeting of the Advisory Council on Alzheimer's Research, Care, and Services. More information about the National Alzheimer's Project Act is available at https://aspe.hhs.gov/national-alzheimers-project-act or meeting page at https://aspe.hhs.gov/advisory-council-alzheimers-rese
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES Friday, April 27, 2018 Printer Friendly Version in PDF Format (13 PDF pages)
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES Friday, April 27, 2018 Printer Friendly Version in PDF Format (13 PDF pages) Age-Friendly Health Systems Amy Berman, Kedar Mate Institute for Healthcare Improvement The John A. Hartford Foundation
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES April 27, 2018 Washington, DC Printer Friendly Version in PDF Format (26 PDF pages) WELCOME AND CHARGE FOR MEETING Laura Gitlin, Ph.D., Johns Hopkins University, Chair
This study expands upon the analysis of the National Health Service Corps (NHSC) begun in “Provider Retention in High Need Areas and continued in “The National Health Service Corps: An Extended Analysis” by using the same techniques used in these earlier studies to examine retention patterns in Indian Health providers.. The study finds a
The development of new drugs and biologics is critical to ensuring that the U.S. population continues to enjoy improvements in quality and length of life. However, pharmaceutical companies must balance this imperative with the need to earn economic returns when making investment decisions. Some drugs, although desirable from a societal perspecti
ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES Friday, January 26, 2018 Printer Friendly Version in PDF Format (14 PDF pages) Overview on NIA preclinical pipeline Eliezer Masliah, M.D. Director, Division of Neuroscience, National Institute on Aging, NIH
State of the Science for Pragmatic Trials of Non-Pharmacological Interventions to Improve Outcomes Among Persons with Dementia and Their Caregivers
This is the PDF version of a Post-Summit Activity Paper prepared for the National Research Summit on Care, Services, and Supports for Persons with Dementia and Their Caregivers (also called the Research Summit on Dementia Care). More information about the Summit is available at https://aspe.hhs.gov/national-research-summit-care-services-and-suppo
Estimating Medical Costs for Regulatory Benefit-Cost Analysis: Conceptual Framework and Best Practices
The U.S. Department of Health and Human Services (HHS) is required to assess the benefits and costs of its major regulations prior to promulgation. To support these assessments, in 2016 HHS issued its Guidelines for Regulatory Impact Analyses , developed under the leadership of its Office of the Assistant Secretary for Planning and Evaluation and